Simplex Trading’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-4,300
| Closed | -$554K | – | 11958 |
|
|
2021
Q3 | $554K | Hold |
4,300
| – | – | ﹤0.01% | 3934 |
|
|
2021
Q2 | $539K | Buy |
4,300
+4,061
| +1,699% | +$512K | ﹤0.01% | 4043 |
|
|
2021
Q1 | $3.24M | Buy |
239
+213
| +819% | +$27.5K | 0.01% | 1159 |
|
|
2020
Q4 | $332K | Sell |
26
-63
| -71% | -$7.39K | ﹤0.01% | 3944 |
|
|
2020
Q3 | $1M | Sell |
89
-343
| -79% | -$34.1K | ﹤0.01% | 2234 |
|
|
2020
Q2 | $4.12M | Sell |
432
-16
| -4% | -$1.54K | 0.01% | 975 |
|
|
2020
Q1 | $4.03M | Buy |
448
+277
| +162% | +$21.5K | 0.01% | 813 |
|
|
2019
Q4 | $906K | Buy |
171
+168
| +5,600% | +$7.66K | ﹤0.01% | 2183 |
|
|
2019
Q3 | $11K | Sell |
3
-143
| -98% | -$6.2K | ﹤0.01% | 6218 |
|
|
2019
Q2 | $599K | Sell |
146
-110
| -43% | -$4.55K | ﹤0.01% | 2404 |
|
|
2019
Q1 | $1.19M | Buy |
256
+255
| +25,500% | +$11.2K | ﹤0.01% | 1843 |
|
|
2018
Q4 | $4K | Sell |
1
-3
| -75% | -$150 | ﹤0.01% | 6364 |
|
|
2018
Q3 | $22K | Sell |
4
-115
| -97% | -$5.65K | ﹤0.01% | 5899 |
|
|
2018
Q2 | $577K | Buy |
119
+79
| +198% | +$2.88K | ﹤0.01% | 2318 |
|
|
2018
Q1 | $7K | Sell |
40
-42
| -51% | -$1.78K | ﹤0.01% | 4402 |
|
|
2017
Q4 | $3K | Sell |
82
-153
| -65% | -$5.74K | ﹤0.01% | 5038 |
|
|
2017
Q3 | $34K | Buy |
235
+223
| +1,858% | +$7.74K | ﹤0.01% | 2667 |
|
|
2017
Q2 | $1K | Sell |
12
-58
| -83% | -$1.68K | ﹤0.01% | 5847 |
|
|
2017
Q1 | $84K | Buy |
70
+20
| +40% | +$527 | ﹤0.01% | 1910 |
|
|
2016
Q4 | $18K | Sell |
50
-11
| -18% | -$349 | ﹤0.01% | 3158 |
|
|
2016
Q3 | $16K | Buy |
+61
| New | +$2.02K | ﹤0.01% | 3217 |
|
|
2016
Q2 | – | Sell |
-10
| Closed | -$5K | – | 6690 |
|
|
2016
Q1 | $5K | Buy |
+10
| New | +$291 | ﹤0.01% | 4159 |
|
|
2015
Q4 | – | Sell |
-190
| Closed | -$92K | – | 6416 |
|
|
2015
Q3 | $92K | Buy |
+190
| New | +$5.71K | 0.01% | 1480 |
|
|
2015
Q2 | – | Sell |
-1
| Closed | -$2K | – | 6091 |
|
|
2015
Q1 | $2K | Sell |
1
-69
| -99% | -$2.74K | ﹤0.01% | 4246 |
|
|
2014
Q4 | $13K | Buy |
+70
| New | +$2.44K | ﹤0.01% | 2410 |
|
Simplex Trading's XLRN Position: Q4 2021 in Review
Simplex Trading sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 1,779 shares — an estimated $229K sold.
Simplex Trading first reported a position in XLRN in Q4 2014 and held it in 22 quarters. The position peaked at $1.08M in Q1 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Simplex Trading reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Simplex Trading sold 1,779 Acceleron Pharma shares in Q4 2021, an estimated $229K.
- Simplex Trading first reported a position in Acceleron Pharma in Q4 2014 and held it in 22 quarters.
- Simplex Trading's Acceleron Pharma position peaked at $1.08M in Q1 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Simplex Trading's 13F filing for Q4 2021, filed 4 Feb 2022.